Registry trials: Alirocumab

20 registry trials linked to Alirocumab with phase phase 3, of 27, newest start first. Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.